314 related articles for article (PubMed ID: 24928858)
1. Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters.
Loughery J; Cox M; Smith LM; Meek DW
Nucleic Acids Res; 2014 Jul; 42(12):7666-80. PubMed ID: 24928858
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
[TBL] [Abstract][Full Text] [Related]
3. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between site-specific modifications on p53 and histone H3.
Warnock LJ; Adamson R; Lynch CJ; Milner J
Oncogene; 2008 Mar; 27(11):1639-44. PubMed ID: 17891183
[TBL] [Abstract][Full Text] [Related]
5. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
6. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
Zeng PY; Berger SL
Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
[TBL] [Abstract][Full Text] [Related]
7. A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation.
Valentine JM; Kumar S; Moumen A
BMC Cancer; 2011 Feb; 11():79. PubMed ID: 21338495
[TBL] [Abstract][Full Text] [Related]
8. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.
Dumaz N; Meek DW
EMBO J; 1999 Dec; 18(24):7002-10. PubMed ID: 10601022
[TBL] [Abstract][Full Text] [Related]
9. HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity.
Phillips A; Teunisse A; Lam S; Lodder K; Darley M; Emaduddin M; Wolf A; Richter J; de Lange J; Verlaan-de Vries M; Lenos K; Böhnke A; Bartel F; Blaydes JP; Jochemsen AG
J Biol Chem; 2010 Sep; 285(38):29111-27. PubMed ID: 20659896
[TBL] [Abstract][Full Text] [Related]
10. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment.
Wang H; Zhao Y; Li L; McNutt MA; Wu L; Lu S; Yu Y; Zhou W; Feng J; Chai G; Yang Y; Zhu WG
J Biol Chem; 2008 Feb; 283(5):2564-74. PubMed ID: 17977830
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of p53 at serine 15 in A549 pulmonary epithelial cells exposed to vanadate: involvement of ATM pathway.
Suzuki K; Inageda K; Nishitai G; Matsuoka M
Toxicol Appl Pharmacol; 2007 Apr; 220(1):83-91. PubMed ID: 17292432
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
Zhao H; Traganos F; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
[TBL] [Abstract][Full Text] [Related]
13. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.
Barlev NA; Liu L; Chehab NH; Mansfield K; Harris KG; Halazonetis TD; Berger SL
Mol Cell; 2001 Dec; 8(6):1243-54. PubMed ID: 11779500
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation.
Hall SR; Campbell LE; Meek DW
Nucleic Acids Res; 1996 Mar; 24(6):1119-26. PubMed ID: 8604347
[TBL] [Abstract][Full Text] [Related]
15. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
[TBL] [Abstract][Full Text] [Related]
16. Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses.
Chao C; Hergenhahn M; Kaeser MD; Wu Z; Saito S; Iggo R; Hollstein M; Appella E; Xu Y
J Biol Chem; 2003 Oct; 278(42):41028-33. PubMed ID: 12909629
[TBL] [Abstract][Full Text] [Related]
17. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
18. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
[TBL] [Abstract][Full Text] [Related]
19. p53-dependent repression of polo-like kinase-1 (PLK1).
McKenzie L; King S; Marcar L; Nicol S; Dias SS; Schumm K; Robertson P; Bourdon JC; Perkins N; Fuller-Pace F; Meek DW
Cell Cycle; 2010 Oct; 9(20):4200-12. PubMed ID: 20962589
[TBL] [Abstract][Full Text] [Related]
20. Protein-protein interactions occur between p53 phosphoforms and ATM and 53BP1 at sites of exogenous DNA damage.
Al Rashid ST; Harding SM; Law C; Coackley C; Bristow RG
Radiat Res; 2011 May; 175(5):588-98. PubMed ID: 21361779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
